Thecompanieswehaveinvestedin.

CLD-9 uses robotics to make personalized medicine scalable, precision formulation built to serve tens of thousands of people a month as it scales.

Agencity's role: Early investor, in before Antler and Boost VC, with the position marked up 6.25x on paper since. Operating partner for go-to-market across India, the US, and the Gulf, including representing the company to investors and partners in Abu Dhabi.

Biomimetic, mussel-inspired polymer chemistry that bonds and coats on wet and submerged surfaces, where conventional adhesives fail. Applications span defense (US Navy contracts), dental, biomedical, and industrial repair. The company has closed a $10M Series A and secured a $40M Department of Defense contract.

Agencity's role: Investor in the Series A-1 round, sourced and led by Arjun. Structuring the company's India entry through a listed Indian real-estate and construction developer.

The fundraising platform for founders: identifies the investors most likely to fund a round using live behavioral signals, automates outreach personalized to each investor's thesis, and manages the raise through to close.

Agencity's role: Investor (July 2026).

Nuron

Nuron builds world models: AI systems that learn a compact internal representation of the world from video and predict how it evolves. The lab is in stealth, and that is deliberate.

Agencity's role: Founding partner.